The Kv7 potassium channel activator flupirtine affects clinical excitability parameters of myelinated axons in isolated rat sural nerve

Journal of the Peripheral Nervous System

Volumn 15, Issue 1, 2010, Pages 63-72

  Sittl, Ruth ^a   Carr, Richard W ^a   Schwarz, Jürgen R ^b   Grafe, Peter ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Axonal excitability; Kv7 channels; Neuropathy; Potassium channel activator; Threshold tracking

Indexed keywords

FLUPIRTINE; POTASSIUM CHANNEL KCNQ;

ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; HYPERPOLARIZATION; IN VITRO STUDY; MALE; NERVE EXCITABILITY; NERVE FIBER; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; SURAL NERVE;

ACTION POTENTIALS; AMINOPYRIDINES; ANALGESICS; ANIMALS; ANTHRACENES; AXONS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; KCNQ POTASSIUM CHANNELS; MALE; MEMBRANE POTENTIALS; MICROELECTRODES; NERVE FIBERS, MYELINATED; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; SURAL NERVE; TIME FACTORS;

EID: 77649247616     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2010.00253.x     Document Type: Article

References (52)

1. Anderson UA, Carson C, McCloskey KD (2009). KCNQ currents and their contribution to resting membrane potential and the excitability of interstitial cells of Cajal from the guinea pig bladder. J Urol 182 : 330 336.
2. Azad SC, Eder M, Simon W, Hapfelmeier G, Dodt HU, Zieglgänsberger W, Rammes G (2004). The potassium channel modulator flupirtine shifts the frequency-response function of hippocampal synapses to favour LTD in mice. Neurosci Lett 370 : 186 190.
3. Baker M, Bostock H, Grafe P, Martius P (1987). Function and distribution of three types of rectifying channel in rat spinal root myelinated axons. J Physiol 383 : 45 67.
4. Barrett EF, Barrett JN (1982). Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J Physiol 323 : 117 144.
5. Bergmans J (1970). The Physiology of Single Human Nerve Fibres. Vander, Louvain.
6. Boerio D, Hogrel JY, Creange A, Lefaucheur JP (2004). Methods and clinical value of peripheral nerve refractory period measurement in man. Neurophysiol Clin 34 : 279 291.
7. Bostock H, Baker M (1988). Evidence for two types of potassium channel in human motor axons in vivo. Brain Res 462 : 354 358.
8. Bostock H, Cikurel K, Burke D (1998). Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 21 : 137 158.
9. Bostock H, Grafe P (1985). Activity-dependent excitability changes in normal and demyelinated rat spinal root axons. J Physiol 365 : 239 257.
10. Brown DA, Passmore GM (2009). Neural KCNQ (Kv7) channels. Br J Pharmacol 156 : 1185 1195.
11. Burke D, Howells J, Trevillion L, McNulty PA, Jankelowitz SK, Kiernan MC (2009). Threshold behaviour of human axons explored using subthreshold perturbations to membrane potential. J Physiol 587 : 491 504.
12. Burke D, Kiernan MC, Bostock H (2001). Excitability of human axons. Clin Neurophysiol 112 : 1575 1585.
13. David G, Modney B, Scappaticci KA, Barrett JN, Barrett EF (1995). Electrical and morphological factors influencing the depolarizing after-potential in rat and lizard myelinated axons. J Physiol 489 : 141 157.
14. Devaux JJ, Kleopa KA, Cooper EC, Scherer SS (2004). KCNQ2 is a nodal K+ channel. J Neurosci 24 : 1236 1244.
15. Friedel HA, Fitton A (1993). Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs 45 : 548 569.
16. Gordon TR, Kocsis JD, Waxman SG (1991). TEA-sensitive potassium channels and inward rectification in regenerated rat sciatic nerve. Muscle Nerve 14 : 640 646.
17. Grafe P, Carr RW, Schwarz JR (2009). The potassium channel activator flupirtine affects multiple excitability parameters of peripheral myelinated axons. J Peripher Nerv Sys 14 (Suppl. 2 59.
18. Gribkoff VK (2003). The therapeutic potential of neuronal KCNQ channel modulators. Expert Opin Ther Targets 7 : 737 748.
19. Gribkoff VK (2008). The therapeutic potential of neuronal KV7 (KCNQ) channel modulators: an update. Expert Opin Ther Targets 12 : 565 581.
20. Grossmann L, Gorodetskaya N, Baron R, Jänig W (2009). Enhancement of ectopic discharge in regenerating A- and C-fibers by inflammatory mediators. J Neurophysiol 101 : 2762 2774.
21. Hlavica P, Niebch G (1985). Pharmacokinetics and biotransformation of the analgesic flupirtine in humans. Arzneimittelforschung 35 : 67 74.
22. Jakob R, Krieglstein J (1997). Influence of flupirtine on a G-protein coupled inwardly rectifying potassium current in hippocampal neurones. Br J Pharmacol 122 : 1333 1338.
23. Kiernan MC, Burke D, Andersen KV, Bostock H (2000). Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 23 : 399 409.
24. Kiernan MC, Isbister GK, Lin CS, Burke D, Bostock H (2005a). Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 57 : 339 348.
25. Kiernan MC, Krishnan AV, Lin CS, Burke D, Berkovic SF (2005b). Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability. Brain 128 : 1841 1846.
26. Kocsis JD, Eng DL, Gordon TR, Waxman SG (1987). Functional differences between 4-aminopyridine and tetraethylammonium-sensitive potassium channels in myelinated axons. Neurosci Lett 75 : 193 198.
27. Kornhuber J, Bleich S, Wiltfang J, Maler M, Parsons CG (1999a). Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication. J Neural Transm 106 : 857 867.
28. Kornhuber J, Maler M, Wiltfang J, Bleich S, Degner D, Ruther E (1999b). Neuronal potassium channel opening with flupirtine. Fortschr Neurol Psychiatr 67 : 466 475.
29. Krishnan AV, Lin CS, Park SB, Kiernan MC (2009). Axonal ion channels from bench to bedside: a translational neuroscience perspective. Prog Neurobiol 89 : 288 313.
30. Kuwabara S, Kanai K, Sung JY, Ogawara K, Hattori T, Burke D, Bostock H (2002). Axonal hyperpolarization associated with acute hypokalemia: multiple excitability measurements as indicators of the membrane potential of human axons. Muscle Nerve 26 : 283 287.
31. Kuwabara S, Misawa S, Tamura N, Kanai K, Hiraga A, Ogawara K, Nakata M, Hattori T (2005). The effects of mexiletine on excitability properties of human median motor axons. Clin Neurophysiol 116 : 284 289.
32. Lang PM, Moalem-Taylor G, Tracey DJ, Bostock H, Grafe P (2006). Activity-dependent modulation of axonal excitability in unmyelinated peripheral rat nerve fibers by the 5-HT(3) serotonin receptor. J Neurophysiol 96 : 2963 2971.
33. Maljevic S, Wuttke TV, Lerche H (2008). Nervous system KV7 disorders: breakdown of a subthreshold brake. J Physiol 586 : 1791 1801.
34. Maurer K, Bostock H, Koltzenburg M (2007). A rat in vitro model for the measurement of multiple excitability properties of cutaneous axons. Clin Neurophysiol 118 : 2404 2412.
35. Maurer K, Hopf HC, Lowitzsch K (1977). Hypokalemia shortens relative refractory period of peripheral sensory nerves in man. J Neurol 216 : 67 71.
36. Miceli F, Soldovieri MV, Martire M, Taglialatela M (2008). Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs. Curr Opin Pharmacol 8 : 65 74.
37. Moalem G, Grafe P, Tracey DJ (2005). Chemical mediators enhance the excitability of unmyelinated sensory axons in normal and injured peripheral nerve of the rat. Neuroscience 134 : 1399 1411.
38. Munro G, Dalby-Brown W (2007). K(v)7 (KCNQ) channel modulators and neuropathic pain. J Med Chem 50 : 2576 2582.
39. Passmore GM, Selyanko AA, Mistry M, Al Qatari M, Marsh SJ, Matthews EA, Dickenson AH, Brown TA, Burbidge SA, Main M, Brown DA (2003). KCNQ/M currents in sensory neurons: significance for pain therapy. J Neurosci 23 : 7227 7236.
40. Rivera-Arconada I, Roza C, Lopez-Garcia JA (2009). Enhancing m currents: a way out for neuropathic pain? Front Mol Neurosci 2 : 10.
41. Roza C, Lopez-Garcia JA (2008). Retigabine, the specific KCNQ channel opener, blocks ectopic discharges in axotomized sensory fibres. Pain 138 : 537 545.
42. + current regulating excitability in the rat node of Ranvier. J Physiol 573 : 17 34.
43. Schwarz JR, Reid G, Bostock H (1995). Action potentials and membrane currents in the human node of Ranvier. Pflugers Arch 430 : 283 292.
44. Sittl R, Carr RW, Schwarz JR, Grafe P (2009). D er Kv7- Kaliumkanalöffner Flupirtin verändert die elektrische Erregbarkeit peripherer myelinisierter Axone. Der Schmerz 23 (Suppl. 1 56.
45. Surti TS, Jan LY (2005). A potassium channel, the M-channel, as a therapeutic target. Curr Opin Investig Drugs 6 : 704 711.
46. Timmann D, Plummer C, Schwarz M, Diener HC (1995). Influence of flupirtine on human lower limb reflexes. Electroencephalogr Clin Neurophysiol 97 : 184 188.
47. Wickenden AD, Naughton-Smith G (2009). Kv7 channels as targets for the treatment of pain. Curr Pharm Des 15 : 1773 1798.
48. Wladyka CL, Kunze DL (2006). KCNQ/M-currents contribute to the resting membrane potential in rat visceral sensory neurons. J Physiol 575 : 175 189.
49. Wua YJ, Dworetzky SI (2005). Recent developments on KCNQ potassium channel openers. Curr Med Chem 12 : 453 460.
50. Wuttke TV, Jurkat-Rott K, Paulus W, Garncarek M, Lehmann-Horn F, Lerche H (2007). Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology 69 : 2045 2053.
51. Xiong Q, Gao Z, Wang W, Li M (2008). Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds. Trends Pharmacol Sci 29 : 99 107.
52. Zaczek R, Chorvat RJ, Saye JA, Pierdomenico ME, Maciag CM, Logue AR, Fisher BN, Rominger DH, Earl RA (1998). Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine. J Pharmacol Exp Ther 285 : 724 730.